Evidence-Based Medicine Guidelines
NOAC versus warfarin post‐PCI in atrial fibrillation
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"NOAC Versus Warfarin post‐PCI in Atrial Fibrillation." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305343/all/NOAC_versus_warfarin_post‐PCI_in_atrial_fibrillation.
NOAC versus warfarin post‐PCI in atrial fibrillation. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305343/all/NOAC_versus_warfarin_post‐PCI_in_atrial_fibrillation. Accessed February 1, 2025.
NOAC versus warfarin post‐PCI in atrial fibrillation. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305343/all/NOAC_versus_warfarin_post‐PCI_in_atrial_fibrillation
NOAC Versus Warfarin post‐PCI in Atrial Fibrillation [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2025 February 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305343/all/NOAC_versus_warfarin_post‐PCI_in_atrial_fibrillation.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - NOAC versus warfarin post‐PCI in atrial fibrillation
ID - 1305343
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305343/all/NOAC_versus_warfarin_post‐PCI_in_atrial_fibrillation
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
